Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25222| Title: | Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCL. | Austin Authors: | Hawkes, Eliza A ;Opat, Stephen;Hertzberg, Mark | Affiliation: | School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia Department of Haematology, Prince of Wales Hospital and University of New South Wales, Randwick, New South Wales, Australia Clinical Haematology Medical Oncology Olivia Newton-John Cancer Research Institute |
Issue Date: | 26-Oct-2020 | Date: | 2020 | Publication information: | Journal of Clinical Oncology 2020; 38(35): 4221-4222 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/25222 | DOI: | 10.1200/JCO.20.02301 | ORCID: | 0000-0002-0376-2559 0000-0002-0308-6458 |
Journal: | Journal of Clinical Oncology | PubMed URL: | 33104442 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.